NCT01192126

Brief Summary

The objective of the study is to evaluate the product performance of visual acuity of the Bausch + Lomb investigational daily disposable contact lenses compared to the currently marketed Johnson \& Johnson Acuvue Moist contact lenses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2010

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

August 30, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 31, 2010

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
3.3 years until next milestone

Results Posted

Study results publicly available

January 3, 2014

Completed
Last Updated

January 3, 2014

Status Verified

November 1, 2013

Enrollment Period

2 months

First QC Date

August 30, 2010

Results QC Date

May 28, 2013

Last Update Submit

November 14, 2013

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual Acuity

    Distance High contrast logMAR visual acuity (VA), difference between the test and control lens at dispensing visit and 1 week follow-up, crossover visit and 1 week follow-up.

    Dispensing Visit and 1 week follow-up

  • Slit Lamp Examination > Grade 2

    Slit lamp findings for each eye will be assessed at each study visit, including epithelial edema, epithelial microcysts, corneal staining, limbal injection, bulbar injection, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates, will be graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). Slit lamp \> 2.

    All study visits from screening through 2 week follow-up

Study Arms (2)

Bausch & Lomb new daily disposable

EXPERIMENTAL

New daily disposable contact lenses

Device: Bausch & Lomb new daily disposable

Johnson & Johnson Acuvue Moist

ACTIVE COMPARATOR

Contact lenses

Device: Johnson & Johnson Acuvue Moist

Interventions

Test lenses are to be worn for approximately one week. Lenses will be worn on a daily wear basis.

Bausch & Lomb new daily disposable

Control lenses are to be worn for approximately one week. Lenses will be worn on a daily wear basis.

Johnson & Johnson Acuvue Moist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects must be adapted soft contact lens wearers that are interested in daily disposable wear or currently adapted daily disposable soft contact lens wearers.
  • Subjects must agree to wear study lenses on a daily disposable basis for approximately one week and crossover to wear another study lens for one week.
  • Subjects must be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
  • Subjects must have clear central corneas that are free of any anterior segment disorders.
  • Subjects must be myopic and require lens correction from -1.00 D to -6.00 diopters (D) in each eye.

You may not qualify if:

  • Subjects who have worn gas permeable contact lenses within the last 30 days or who have worn polymethylmethacrylate lenses within the last 3 months.
  • Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an affect on ocular health during the course of the study.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects with an active ocular disease or who are using any ocular medication.
  • Subjects who are not correctable to 32 letters (0.3 logMAR) in each eye with soft spherical contact lenses.
  • Subjects who currently wear monovision, multifocal, or toric contact lenses.
  • Subjects with an ocular astigmatism of 1.00 D or greater in either eye.
  • Subjects with anisometropia (spherical equivalent) of greater than 1.00 D.
  • Subjects with any grade 2 or greater finding during the slit lamp examination (refer to Appendix B for methods of clinical evaluation).
  • Subjects with corneal infiltrates, of ANY GRADE, are not eligible.
  • Subjects with any "Present" finding during the slit lamp examination (refer to Appendix B for methods of clinical evaluation) that, in the Investigator's judgment, interferes with contact lens wear.
  • Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
  • Subjects who are aphakic.
  • Subjects who are amblyopic.
  • Subjects who have presbyopia.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bausch & Lomb

Rochester, New York, 14609, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr. Robert Steffen OD
Organization
Bausch & Lomb Incorporated

Study Officials

  • Bev Barna

    Bausch & Lomb Incorporated

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 30, 2010

First Posted

August 31, 2010

Study Start

August 1, 2010

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

January 3, 2014

Results First Posted

January 3, 2014

Record last verified: 2013-11

Locations